Cyclic fatigue test block. by Beliz Özel (16475132)

Platinum(II) Iodido Complexes of 7-Azaindoles with Significant Antiproliferative Effects: An Old Story Revisited with Unexpected Outcomes by Pavel Štarha (490367)

“…Complexes showed high <i>in vitro</i> cytotoxicity against nine human cancer cell lines (IC₅₀ ranging from 0.4 to 12.8 μM), including the <i>cisplatin</i>-resistant ovarian cancer cell line (A2780R; IC₅₀ = 1.0–3.5 μM). …”

Response of a Habitat-Forming Marine Plant to a Simulated Warming Event Is Delayed, Genotype Specific, and Varies with Phenology by Laura K. Reynolds (318282)

“…However, after returning temperature to ambient levels, we found strongly negative, delayed effects of warming on production: shoot production declined by 27% and total biomass decreased by 50% relative to individuals that had not been warmed. …”

Standardized differences between the unweighted SCAPIS participants and weighted SCAPIS participants standardized to match the target population on individual and neighborhood-leve... by Carl Bonander (5563244)

GFP localization and expression in wild-type and <i>tbc-2</i> mutants. by İçten Meraş (13184380)

Binding of nucleotide and compound 1 to yeast F₁ α- and β-subunits. by Lindsay B. Tulloch (1266861)

B-THP-Ts bind to C-terminal GFP-PTP tagged F₁ α- and β- subunits. by Lindsay B. Tulloch (1266861)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)

2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D₁ Receptor for... by Javier García-Cárceles (2073898)

Effects of compounds on mitochondrial membrane potential. by Lindsay B. Tulloch (1266861)

Inhibition of ATP production in digitonin-permeabilsed cells. by Lindsay B. Tulloch (1266861)

Effect of potassium channels blockade on relaxation induced by CNP. by Carolina Caniffi (444744)

Different scenarios of hidden hearing loss have additive effects on SGN activity. by Maral Budak (6680351)

“…<p>(A) Sound-evoked CAPs of SGN fiber populations with different myelinopathy and synaptopathy scenarios at 70dB SPL, averaged over 50 simulations (dashed lines correspond to the peaks of each CAP, labeled with the same colors as the CAPs). …”

DAF-16 FOXO localizes to vesicles in intestinal cells. by İçten Meraş (13184380)

Keeping constant channel number as length of unmyelinated segment, <i>L</i>_<i>u</i>, is increased leads to similar effects on cumulative CAP as keeping constant channel... by Maral Budak (6680351)

“…<p>(A)Sound-evoked CAPs of SGN fiber populations with varied <i>L</i>_<i>u</i> at 70dB SPL, averaged over 50 simulations (dashed lines correspond to the peaks of each CAP, labeled with the same colors as the CAPs). …”

Maintaining channel density at the heminode as its length, <i>L</i>_<i>h</i>, is varied reduces effects on cumulative CAP compared to keeping constant channel number. by Maral Budak (6680351)

“…<p>(A) Sound-evoked CAPs of SGN fiber populations with varied <i>L</i>_<i>h</i> at 70dB SPL, averaged over 50 simulations (dashed lines correspond to the peaks of each CAP, labeled with the same colors as the CAPs). …”

Manager’s characteristics. by Martina Wallberg (16052714)